Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population. Issue 3 (22nd December 2017)

• Record Type: Journal Article
• Authors: Zang, Feng; Yue, Ming; Yao, Yinan; Liu, Mei; Fan, Haozhi; Feng, Yue; Xia, Xueshan; Huang, Peng; Yu, Rongbin
• Is Part Of: Epidemiology and infection. Volume 146:Issue 3(2018)
• Page Start: 379
• Page End: 385
• Publication Date: 2017-12-22
• Subjects: Chronic hepatitis C, -- IL28B, -- MxA, -- spontaneous clearance, -- treatment response; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268817002928
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: The high rate of chronic hepatitis C (CHC) was one of the key issues of global public health concern. Interferon ( IFN ) -λ relevant genes were in the antiviral treatment pathway, not only influenced hepatitis C virus (HCV) spontaneous clearance, but also affected the IFN-mediated viral clearance. The aim of this study was to identify the association of interleukin 28B ( IL28B ), myxovirus resistance A ( MxA ) gene polymorphisms with HCV spontaneous clearance and therapeutic response in Chinese CHC patients. IL28B and MxA gene genotypes were detected among 231 CHC carriers, 428 subjects with HCV spontaneous clearance and 662 CHC patients with pegylated IFN- α and ribavirin (pegIFN- α /RBV) treatment. Patients with MxA rs2071430 TT genotype were more likely to develop HCV infection chronicity (additive model: odds ratio (OR) 1.22, 95% confidence interval (CI) 1.01–1.48, P = 0.042). IL28B rs1298075 variant genotypes (additive model: OR 0.58, 95% CI 0.34–0.98, P = 0.040) and MxA rs17000900 variant genotypes (additive model: OR 0.54, 95% CI 0.30–0.99, P = 0.048) were less likely to achieve a sustained virological response. The life table indicated that patients with IL28B rs1298075 AG genotype were slower to achieve a viral load <500 copies/ml ( P = 0.018). During the treatment, the downward trend in viral load was different among each IL28B rs1298075 genotype, especially in subgroup with a baseline HCV-RNA >10 6 copies/ml (all P < 0.05). This study illustrated that the carriage of IL28B rs12980275 AA had a positive effect on treatment response to pegIFN- α /RBV among Chinese CHC patients.